BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 38086292)

  • 1. Non-coding RNAs (ncRNAs) and multidrug resistance in glioblastoma: Therapeutic challenges and opportunities.
    Subaiea GM; Syed RU; Afsar S; Alhaidan TMS; Alzammay SA; Alrashidi AA; Alrowaili SF; Alshelaly DA; Alenezi AMSRA
    Pathol Res Pract; 2024 Jan; 253():155022. PubMed ID: 38086292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.
    Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ncRNA-TGF-β axis: Unveiling new frontiers in colorectal cancer research.
    Alharbi KS
    Pathol Res Pract; 2024 Feb; 254():155138. PubMed ID: 38266458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the roles of non-coding RNAs and angiogenesis in glioblastoma: An overview of current research and future perspectives.
    Song Z; Xue Z; Wang Y; Imran M; Assiri M; Fahad S
    Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130567. PubMed ID: 38242182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.
    Rahnama S; Bakhshinejad B; Farzam F; Bitaraf A; Ghazimoradi MH; Babashah S
    Life Sci; 2021 Jul; 277():119488. PubMed ID: 33862117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
    Feng Q; Zhang H; Yao D; Chen WD; Wang YD
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNAs in Multidrug Resistance of Glioblastoma.
    Mahinfar P; Baradaran B; Davoudian S; Vahidian F; Cho WC; Mansoori B
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33806782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ncRNADrug: a database for validated and predicted ncRNAs associated with drug resistance and targeted by drugs.
    Cao X; Zhou X; Hou F; Huang YE; Yuan M; Long M; Chen S; Lei W; Zhu J; Chen J; Zhang T; Guo AY; Jiang W
    Nucleic Acids Res; 2024 Jan; 52(D1):D1393-D1399. PubMed ID: 37953323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Roles and Potential Applications of Non-Coding RNAs in Glioblastoma.
    DeOcesano-Pereira C; Machado RAC; Chudzinski-Tavassi AM; Sogayar MC
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in cancer and cancer stem cells.
    Huang T; Alvarez A; Hu B; Cheng SY
    Chin J Cancer; 2013 Nov; 32(11):582-93. PubMed ID: 24206916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal noncoding RNAs: key players in glioblastoma drug resistance.
    Movahedpour A; Khatami SH; Khorsand M; Salehi M; Savardashtaki A; Mirmajidi SH; Negahdari B; Khanjani N; Naeli P; Vakili O; Taheri-Anganeh M
    Mol Cell Biochem; 2021 Nov; 476(11):4081-4092. PubMed ID: 34273059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma.
    Zhao C; Gao Y; Guo R; Li H; Yang B
    Invest New Drugs; 2020 Oct; 38(5):1227-1235. PubMed ID: 31823158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
    Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
    Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer.
    Kazmi I; Altamimi ASA; Afzal M; Majami AA; AlGhamdi AS; Alkinani KB; Abbasi FA; Almalki WH; Alzera SI; Kukreti N; Fuloria NK; Sekar M; Abida
    Pathol Res Pract; 2024 Feb; 254():155134. PubMed ID: 38277746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic characterization and biological functions of non-coding RNAs in glioblastoma.
    Dai L; Liang W; Shi Z; Li X; Zhou S; Hu W; Yang Z; Wang X
    Cell Prolif; 2023 Mar; 56(3):e13375. PubMed ID: 36457281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNA dysregulation in skin cancers.
    Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
    Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).
    Zeng Z; Chen Y; Geng X; Zhang Y; Wen X; Yan Q; Wang T; Ling C; Xu Y; Duan J; Zheng K; Sun Z
    Int J Oncol; 2022 Jun; 60(6):. PubMed ID: 35506469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protean world of non-coding RNAs in glioblastoma.
    Paulmurugan R; Malhotra M; Massoud TF
    J Mol Med (Berl); 2019 Jul; 97(7):909-925. PubMed ID: 31129756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting non-coding RNAs to overcome cancer therapy resistance.
    Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
    Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.